Breaking News Instant updates and real-time market news.

IDRA

Idera Pharmaceuticals

$7.22

0.16 (2.27%)

16:40
11/06/18
11/06
16:40
11/06/18
16:40

Idera Pharmaceuticals sees sufficient funds into Q1 of 2020

The company currently anticipates that, based on its current operating plan, its existing cash and cash equivalents will be sufficient to fund company operations into Q1 of 2020.

IDRA Idera Pharmaceuticals
$7.22

0.16 (2.27%)

08/15/18
JPMS
08/15/18
INITIATION
Target $15
JPMS
Overweight
Idera Pharmaceuticals resumed with an Overweight at JPMorgan
JPMorgan analyst Anupam Rama resumed coverage of Idera Pharmaceuticals with an Overweight rating and $15 price target following a period of restriction. Rama tells investors in a research note that Idera's Q2 results highlighted its continued prioritization of IMO-2125 in oncology, and views IMO-2125 as an underappreciated asset at current levels. Looking ahead, Rama believes the TLR9 space is gaining increased interest, and says date to data for IMO-2125 are differentiated in PD-1 refractory metastatic melanoma.
08/15/18
08/15/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Cision (CISN) initiated with an Outperform at William Blair. 2. ObsEva (OBSV) resumed with an Outperform at Leerink. 3. Idera Pharmaceuticals (IDRA) resumed with an Overweight at JPMorgan. 4. DTE Energy (DTE) initiated with an Equal Weight at Barclays. 5. Tellurian (TELL) initiated with an Outperform at Baird. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/24/18
LEHM
09/24/18
INITIATION
Target $14
LEHM
Overweight
Idera Pharmaceuticals initiated with an Overweight at Barclays
Barclays analyst Gena Wang started Idera Pharmaceuticals with an Overweight rating and $14 price target. Tilsotolimod, when coupled with ipilimumab, has shown encouraging initial activity in PD-1 refractory melanoma patients, Wang tells investors in a research note. The analyst sees a favorable risk/reward profile into upcoming data readouts.
09/24/18
09/24/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Idera Pharmaceuticals (IDRA) initiated with an Overweight at Barclays. 2. Caesars (CZR) Entertainment initiated with a Sell at UBS. 3. GreenTree Hospitality (GHG) initiated with a Neutral at Goldman Sachs. 4. AMD (AMD) initiated with an Outperform at RBC Capital. 5. Vonage (VG) assumed with an Outperform at William Blair. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

BE

Bloom Energy

$16.04

0.56 (3.62%)

08:08
11/19/18
11/19
08:08
11/19/18
08:08
Hot Stocks
Bloom Energy enters strategic partnership with SK E&C »

SK Group and Bloom Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

DRRX

Durect

$0.91

-0.0094 (-1.02%)

08:07
11/19/18
11/19
08:07
11/19/18
08:07
Hot Stocks
Durect amends ongoing Phase 2a trial of DUR-928 »

Durect announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CACI

CACI

$180.35

-0.03 (-0.02%)

08:07
11/19/18
11/19
08:07
11/19/18
08:07
Hot Stocks
CACI awarded $413M contract for U.S. Army communications systems support »

CACI International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLND

Talend

$37.44

-1.13 (-2.93%)

08:07
11/19/18
11/19
08:07
11/19/18
08:07
Recommendations
Talend analyst commentary  »

Talend price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

MGTA

Magenta Therapeutics

$7.50

0.4 (5.63%)

08:06
11/19/18
11/19
08:06
11/19/18
08:06
Hot Stocks
Magenta Therapeutics names Jason Ryan as Chief Operating and Financial Officer »

Magenta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

NERV

Minerva

$8.41

0.11 (1.33%)

08:06
11/19/18
11/19
08:06
11/19/18
08:06
Hot Stocks
Minerva announces results from roluperidone study »

Minerva announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

BKI

Black Knight

$49.77

0.87 (1.78%)

, DNB

Dun & Bradstreet

$142.27

0.11 (0.08%)

08:05
11/19/18
11/19
08:05
11/19/18
08:05
Hot Stocks
Black Knight board approves $375M investment in Dun & Bradstreet »

Black Knight (BKI)…

BKI

Black Knight

$49.77

0.87 (1.78%)

DNB

Dun & Bradstreet

$142.27

0.11 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 03

    Dec

CMP

Compass Minerals

$52.49

0.98 (1.90%)

08:04
11/19/18
11/19
08:04
11/19/18
08:04
Hot Stocks
Compass Minerals CEO to step down, Dick Grant named interim CEO »

Compass Minerals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LANC

Lancaster Colony

$182.53

-0.21 (-0.11%)

08:03
11/19/18
11/19
08:03
11/19/18
08:03
Hot Stocks
Lancaster Colony acquires assets of Omni Baking Company for $25M »

Lancaster Colony…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TENX

Tenax Therapeutics

$3.80

(0.00%)

08:03
11/19/18
11/19
08:03
11/19/18
08:03
Hot Stocks
Tenax activates first clinical research site for Phase 2 trial of levosimendan »

Tenax Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLDB

Solid Biosciences

$33.82

2.81 (9.06%)

, SRPT

Sarepta

$119.02

0.14 (0.12%)

08:02
11/19/18
11/19
08:02
11/19/18
08:02
Conference/Events
Morgan Stanley to hold a bus trip »

Biotech Boston Bus Trip…

SLDB

Solid Biosciences

$33.82

2.81 (9.06%)

SRPT

Sarepta

$119.02

0.14 (0.12%)

NTGN

Neon Therapeutics

$6.98

-0.1 (-1.41%)

EDIT

Editas Medicine

$29.00

0.92 (3.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

NEE

NextEra Energy

$180.41

1.27 (0.71%)

08:02
11/19/18
11/19
08:02
11/19/18
08:02
Hot Stocks
NextEra Energy Transmission to acquire Trans Bay Cable for approximately $1B »

NextEra Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

KMB

Kimberly-Clark

$111.22

0.43 (0.39%)

08:01
11/19/18
11/19
08:01
11/19/18
08:01
Periodicals
Kimberly-Clark won't sell European tissue business with bids too low, FT says »

Kimberly-Clark will call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:01
11/19/18
11/19
08:01
11/19/18
08:01
Conference/Events
Bernstein to hold a symposium »

5th Annual Asset…

NEE

NextEra Energy

$180.41

1.27 (0.71%)

08:01
11/19/18
11/19
08:01
11/19/18
08:01
Hot Stocks
Breaking Hot Stocks news story on NextEra Energy »

NextEra Energy to acquire…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

08:01
11/19/18
11/19
08:01
11/19/18
08:01
Conference/Events
Wedbush to hold a tour »

2018 Holiday Shopping…

HP

Helmerich & Payne

$62.59

2.54 (4.23%)

08:00
11/19/18
11/19
08:00
11/19/18
08:00
Upgrade
Helmerich & Payne rating change  »

Helmerich & Payne…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SASR

Sandy Spring Bancorp

07:57
11/19/18
11/19
07:57
11/19/18
07:57
Upgrade
Sandy Spring Bancorp rating change  »

Sandy Spring Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBH

Sally Beauty

$20.61

-0.425 (-2.02%)

07:57
11/19/18
11/19
07:57
11/19/18
07:57
Recommendations
Sally Beauty analyst commentary  »

Sally Beauty price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NHLD

National Holdings Corp

$2.96

(0.00%)

07:57
11/19/18
11/19
07:57
11/19/18
07:57
Hot Stocks
Breaking Hot Stocks news story on National Holdings Corp »

National Holdings Corp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QIWI

Qiwi

$14.15

-0.28 (-1.94%)

07:55
11/19/18
11/19
07:55
11/19/18
07:55
Conference/Events
Qiwi to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

MDGL

Madrigal Pharmaceuticals

$129.47

-3.36 (-2.53%)

07:54
11/19/18
11/19
07:54
11/19/18
07:54
Recommendations
Madrigal Pharmaceuticals analyst commentary  »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

BAX

Baxter

$66.49

0.68 (1.03%)

07:54
11/19/18
11/19
07:54
11/19/18
07:54
Recommendations
Baxter analyst commentary  »

Baxter confident in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 05

    Dec

LONE

Lonestar Resources

$7.03

-0.32 (-4.35%)

07:52
11/19/18
11/19
07:52
11/19/18
07:52
Hot Stocks
Lonestar Resources announces Eagle Ford shale acquisition »

Lonestar Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

GOOGL

Alphabet Class A

$1,069.13

-2.09 (-0.20%)

, GOOG

Alphabet

$1,062.01

-2.73 (-0.26%)

07:52
11/19/18
11/19
07:52
11/19/18
07:52
Recommendations
Alphabet Class A, Alphabet, Oracle analyst commentary  »

JMP says former Oracle…

GOOGL

Alphabet Class A

$1,069.13

-2.09 (-0.20%)

GOOG

Alphabet

$1,062.01

-2.73 (-0.26%)

ORCL

Oracle

$51.19

0.55 (1.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 05

    Dec

  • 06

    Dec

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.